Anchorage-dependent transcription of the cyclin A gene

Molecular and Cellular Biology

Volumn 16, Issue 9, 1996, Pages 4632-4638

  Schulze, Almut ^a   Zerfass Thome, Karin ^a   Bergès, Josette ^b   Middendorp, Sandrine ^b   Jansen Dürr, Pidder ^a   Henglein, Berthold ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; ENZYME INHIBITOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL ADHESION; CELL CYCLE; CELL STRAIN 3T3; ENZYME INHIBITION; ENZYME SUBSTRATE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALIA;

EID: 0029783294     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.9.4632     Document Type: Article

References (70)

1. Amigorena, S., C. Bonnerot, J. R. Drake, D. Choquet, W. Hunziker, J. G. Guillet, P. Webster, C. Sautes, I. Mellman, and W. H. Fridman. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 256:1808-1812.
2. Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821.
3. Bates, S., and G. Peters. 1995. Cyclin D1 as a cellular proto-oncogene. Semin. Cancer Biol. 6:73-82.
4. Beijersbergen, R. L., L. Carlee, R. M. Kerkhoven, and R. Bernards. 1995. Regulation of the retinoblastoma protein-related p107 by G(1) cyclin complexes. Genes Dev. 9:1340-1353.
5. Bohmer, R. M., E. Scharf, and R. K. Assoian. 1996. Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. Mol. Biol. Cell 7:101-111.
6. Burridge, K., and K. Fath. 1989. Focal contacts: transmembrane links between the extracellular matrix and the cytoskeleton. Bioessays 10:104-108.
7. Cardoso, M. C., H. Leonhardt, and B. Nadalginard. 1993. Reversal of terminal differentiation and control of DNA replication - cyclin-A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74:979-992.
8. Clark, E. A., and J. S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233-239.
9. D'Urso, G., R. L. Marraccino, D. R. Marshak, and J. M. Roberts. 1990. Cell cycle control of DNA replication by a homologue from human cells of the p34cdc2 protein kinase. Science 250:786-791.
10. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
11. Dulic, V., L. F. Drullinger, E. Lees, S. I. Reed, and G. H. Stein. 1993. Altered regulation of G(1)-cyclins in senescent human diploid fibroblasts - accumulation of inactive cyclin-E-Cdk2 and cyclin-D1-Cdk2 complexes. Proc. Natl. Acad. Sci. USA 90:11034-11038.
12. Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
13. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
14. Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti. 1996. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271: 499-502.
15. Girard, F., U. Strausfeld, A. Fernandez, and N. J. Lamb. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67:1169-1179.
16. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
17. Gramlich, T. L., C. R. Fritsch, D. Maurer, M. Eberle, and T. S. Gansler. 1994. Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma. Diagn. Mol. Pathol. 3:255-259.
18. Guadagno, T., M. Ohtsubo, J. M. Roberts, and R. Assoian. 1993. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262:1572-1575.
19. Guadagno, T. M., and R. K. Assoian. 1991. G1/S control of anchorage-independent growth in the fibroblast cell cycle. J. Cell Biol. 115:1419-1425.
20. Hall, M., S. Bates, and G. Peters. 1995. Evidence for different modes of action of cydin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11:1581-1588.
21. Han, E. K., T. M. Guadagno, S. L. Dalton, and R. K. Assoian. 1993. A cell cycle and mutational analysis of anchorage-independent growth: cell adhesion and TGF-beta 1 control G1/S transit specifically. J. Cell Biol. 122:461-471.
22. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 CDK-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
23. Henglein, B., X. Chenivesse, J. Wang, D. Eick, and C. Bréchot. 1994. Structure and cell cycle regulated transcription of the human cyclin A gene. Proc. Natl. Acad. Sci. USA 91:5490-5494.
24. Hengst, L., V. Dulic, J. M. Slingerland, E. Lees, and S. I. Reed. 1994. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91:5291-5295.
25. Hiebert, S. W., S. P. Chellappan, J. M. Horowitz, and J. R. Nevins. 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:177-185.
26. Hinds, P. W., S. F. Dowdy, E. N. Eaton, A. Arnold, and R. A. Weinberg. 1994. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91:709-713.
27. Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
28. Hunter, T., and J. Pines. 1994. Cyclins and cancer. 2. Cyclin D and CDK inhibitors come of age. Cell 79:573-582.
29. Jansen-Dürr, P., A. Meichle, P. Steiner, M. Pagano, K. Finke, J. Botz, J. Weßbecher, G. Draetta, and M. Eilers. 1993. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA 90:2547-2552.
30. Kato, J.-Y., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
31. Kato, J. Y., M. Matsuoka, K. Polyak, J. Massagué, and C. J. Sherr. 1994. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27(Kip1)) of cyclin-dependent kinase 4 activation. Cell 79:487-496.
32. Koff, A., F. Cross, A. Fisher, J. Schumacher, K. Leguellec, M. Philippe, and J. M. Roberts. 1991. Human cyclin E, a new cyclin that interacts with two members of the cdc2 gene family. Cell 66:1217-1228.
33. Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Kaelin, and D. M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161-172.
34. La Thangue, N. B. 1994. Drtf1/E2F - an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19:108-114.
35. Lees, E., B. Faha, V. Dulic, S. I. Reed, and E. Harlow. 1992. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 6:1874-1885.
36. Matsuhisa, T., and Y. Mori. 1981. An anchorage-dependent locus in the cell cycle for the growth of 3T3 cells. Exp. Cell Res. 135:393-398.
37. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
38. Musgrove, E. A., B. Sarcevic, and R. L. Sutherland. 1996. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation. J. Cell. Biochem. 60:363-378.
39. Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. H. Lee, J. Massagué, G. R. Crabtree, and J. M. Roberts. 1994. Interleukin-2-mediated elimination of the p27(Kip1) cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (London) 372:570-573.
40. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
41. Otsuka, H., and M. Moskowitz. 1975. Arrest of 3T3 cells in G1 phase in suspension culture. J. Cell Physiol. 87:213-219.
42. Pagano, M., G. Draetta, and P. Jansen-Dürr. 1992. Association of cdk2 kinase with the transcription factor E2F during S phase. Science 255:1144-1147.
43. Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:961-971.
44. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Delsal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
45. Pines, J. 1993. Cyclins and cyclin-dependent kinases - take your partners. Trends Biochem. Sci. 18:195-197.
46. Pines, J., and T. Hunter. 1990. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature (London) 346:760-763.
47. Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27KIP1, a cyclin-Cdk inhibitor, links transformation growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.
48. Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27(Kip1), a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
49. Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J. Y. Kato, D. Barsagi, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates G(1) phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
50. Rao, S., C. Chu, and S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259-5267.
51. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669-1679.
52. Rudolph, B., R. Saffrich, J. Zwicker, B. Henglein, R. Müller, W. Ansorge, and M. Eilers. 1996. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A. hut not apoptosis. EMBO J. 15:3065-3076.
53. Schulze, A., K. Zerfaß, D. Spitkovsky, J. Berges, S. Middendorp, P. Jansen-Dürr, and B. Henglein. 1995. Cell cycle regulation of cyclin A gene transcription is mediated by a variant E2F binding site. Proc. Natl. Acad. Sci. USA 92:11264-11268.
54. Schulze, A., K. Zerfass, D. Spitkovsky, B. Henglein, and P. Jansen-Dürr. 1994. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Oncogene 9:3475-3482.
55. Sherr, C. J. 1993. Mammalian G(1)-cyclins. Cell 73:1059-1065.
56. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G(1) cyclin-dependent kinases. Genes Dev. 9:1149-1163.
57. Shin, S. I., V. H. Freedman, R. Risser, and R. Pollack. 1975. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc. Natl. Acad. Sci. USA 72:4435-4439.
58. Shiyanov, P., S. Bagchi, G. Adami, J. Kokonlis, N. Hay, M. Arroyo, A. Morozov, and P. Raychaudhuri. 1996. p21 disrupts the interaction between cdk2 and the E2F-p130 complex. Mol. Cell. Biol. 16:737-744.
59. Suzuki-Takahashi, I., M. Kitagawa, M. Saijo, H. Higashi, H. Ogino, H. Matsumoto, Y. Taya, S. Nishimura, and A. Okuyama. 1995. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase. Oncogene 10:1691-1698.
60. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
61. Wang, J., X. Chenivesse, B. Henglein, and C. Bréchot. 1990. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature (London) 343:555-557.
62. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
63. Won, K. A., Y. Xiong, D. Beach, and M. Z. Gilman. 1992. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA 89:9910-99104.
64. Zamanian, M., and N. B. LaThangue. 1993. Transcriptional repression by the Rb-related protein-p107. Mol. Biol. Cell 4:389-396.
65. Zerfass, K., A. Schulze, D. Spitkovsky, V. Friedman, B. Henglein, and P. Jansen-Dürr. 1995. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J. Virol. 69:6389-6399.
66. 65a. Zerfass-Thome, K. Unpublished data.
67. 65b. Zerfass-Thome, K., et al. Unpublished data.
68. Zhou, P., W. Jiang, Y. J. Zhang, S. M. Kahn, I. Schieren, R. M. Santella, and I. B. Weinstein. 1995. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 11: 571-580.
69. Zhu, L., E. Harlow, and B. D. Dynlacht. 1995. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interaction with E2F. Genes Dev. 9:1740-1752.
70. Zindy, F., E. Lamas, X. Chenivesse, J. Sobczak, D. Fesquet, J. Wang, B. Henglein, and C. Bréchot. 1991. Cyclin A is required in S phase in normal epithelial cells. Biophys. Biochem. Res. Commun. 182:1144-1154.